{"disease":{"id":"human-papillomavirus-disease","name":"human papillomavirus disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02993757","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02979535","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}